目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT: CARRIER SCREENING MARKET

2 RESEARCH METHODOLOGY (Page No. - 36)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
FIGURE 2 KEY SECONDARY SOURCES
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION: MARKET
2.2.2 GROWTH FORECAST
FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MARKET
2.8 IMPACT OF ECONOMIC RECESSION ON MARKET

3 EXECUTIVE SUMMARY (Page No. - 50)
FIGURE 11 CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 CARRIER SCREENING INDUSTRY, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY MEDICAL CONDITION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 15 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 55)
4.1 CARRIER SCREENING MARKET OVERVIEW
FIGURE 17 GROWING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET
4.2 CARRIER SCREENING INDUSTRY FOR EXPANDED CARRIER SCREENING, BY TYPE, 2023-2028
FIGURE 18 PREDESIGNED PANEL TESTING SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.3 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE AND COUNTRY, 2023
FIGURE 19 US AND PRODUCTS TO DOMINATE NORTH AMERICAN MARKET IN 2023
4.4 GEOGRAPHICAL GROWTH OPPORTUNITIES: MARKET
FIGURE 20 US TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD

5 MARKET OVERVIEW (Page No. - 57)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: CARRIER SCREENING MARKET
5.2.1 DRIVERS
5.2.1.1 Increasing emphasis on early disease detection and prevention
5.2.1.2 Growing prevalence of genetic disorders
5.2.1.3 High risk of chromosomal abnormalities with advancing maternal age
TABLE 2 GLOBAL INCIDENCE RATE OF TRISOMY
5.2.1.4 Increased focus on preconception and prenatal testing
5.2.1.5 Rising number of fertility clinics and IVF centers
5.2.1.6 Declining rate of fertility
TABLE 3 FERTILITY RATE (BIRTHS PER WOMAN), BY COUNTRY
5.2.2 RESTRAINTS
5.2.2.1 Ethical concerns in preconception genetic carrier screening
5.2.2.2 High cost of carrier screening
5.2.3 OPPORTUNITIES
5.2.3.1 Increased awareness about reproductive health in emerging economies
FIGURE 22 HEALTHCARE EXPENDITURE PER CAPITA IN BRICS, 2012-2020
5.2.3.2 Integration with telehealth and digital health platforms
5.2.3.3 Increased number of collaborations and partnerships among healthcare organizations
5.2.3.4 Increasing number of government initiatives and policies toward genetic health improvement
5.2.3.5 Growing focus on health screening for rare diseases
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
5.2.4.2 Lack of standard guidelines for carrier screening
5.3 TRENDS
5.3.1 LACK OF PUBLIC INTEREST IN EXPANDED CARRIER SCREENING
5.4 PRICING ANALYSIS
TABLE 4 INDICATIVE PRICING OF CARRIER SCREENING PRODUCTS/SERVICES
TABLE 5 AVERAGE SELLING PRICE OF PREIMPLANTATION GENETIC TESTING SYSTEMS
5.5 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES: CARRIER SCREENING INDUSTRY
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 ECOSYSTEM/MARKET MAP
FIGURE 25 ECOSYSTEM/MARKET MAP: MARKET
TABLE 7 ROLE IN ECOSYSTEM: CARRIER SCREENING INDUSTRY
FIGURE 26 KEY PLAYERS IN MARKET
5.9 TARIFF & REGULATORY LANDSCAPE
TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MARKET
5.9.1 NORTH AMERICA
5.9.1.1 US
5.9.1.2 Canada
5.9.2 EUROPE
5.9.2.1 UK
5.9.2.2 France
5.9.3 ASIA PACIFIC
5.9.3.1 Japan
5.9.3.2 India
5.10 PATENT ANALYSIS
5.10.1 PATENT TRENDS FOR CARRIER SCREENING
FIGURE 27 PATENT TRENDS FOR CARRIER SCREENING, JANUARY 2013-DECEMBER 2023
5.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR CARRIER SCREENING PATENTS, JANUARY 2013- DECEMBER 2023
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.11.1 REVENUE SHIFT AND REVENUE POCKETS FOR CARRIER SCREENING MANUFACTURERS
FIGURE 29 REVENUE SHIFT FOR CARRIER SCREENING PRODUCTS/SERVICES
5.12 KEY CONFERENCES & EVENTS
TABLE 9 DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
5.13 TECHNOLOGY ANALYSIS
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CARRIER SCREENING PRODUCTS
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CARRIER SCREENING PRODUCTS (%)
5.14.2 BUYING CRITERIA
FIGURE 31 KEY BUYING CRITERIA FOR END USERS OF CARRIER SCREENING PRODUCTS/SERVICES
TABLE 11 KEY BUYING CRITERIA FOR END USERS OF CARRIER SCREENING PRODUCTS/SERVICES
5.15 TRADE ANALYSIS
TABLE 12 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)
TABLE 13 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)

6 CARRIER SCREENING MARKET, BY PRODUCT & SERVICE (Page No. - 80)
6.1 INTRODUCTION
TABLE 14 CARRIER SCREENING INDUSTRY, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
6.2 SERVICES
6.2.1 RISING NUMBER OF ACCREDITED LABORATORIES AND GENETIC CASES TO DRIVE MARKET
TABLE 15 MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
6.3 PRODUCTS
6.3.1 GROWING INCIDENCE OF CHROMOSOMAL ABNORMALITIES AND RISING USE OF CARRIER SCREENING TESTS TO DRIVE MARKET
TABLE 16 KEY PLAYERS PROVIDING CARRIER SCREENING PRODUCTS
TABLE 17 MARKET FOR PRODUCTS, BY REGION, 2021-2028 (USD MILLION)

7 CARRIER SCREENING MARKET, BY TYPE (Page No. - 84)
7.1 INTRODUCTION
TABLE 18 CARRIER SCREENING INDUSTRY, BY TYPE, 2021-2028 (USD MILLION)
7.2 EXPANDED CARRIER SCREENING
TABLE 19 MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 20 MARKET FOR EXPANDED CARRIER SCREENING, BY REGION, 2021-2028 (USD MILLION)
7.2.1 PREDESIGNED PANEL TESTING
7.2.1.1 Predesigned panel testing segment to command larger market share during forecast period
TABLE 21 PREDESIGNED PANEL TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
7.2.2 CUSTOMIZED PANEL TESTING
7.2.2.1 Better customization options for meeting specific customer requirements to drive segment
TABLE 22 CUSTOMIZED PANEL TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3 TARGETED DISEASE CARRIER SCREENING
7.3.1 INTRODUCTION OF PANELS FOR SIMULTANEOUSLY SCREENING MULTIPLE GENETIC CONDITIONS TO DRIVE MARKET
TABLE 23 MARKET FOR TARGETED DISEASE CARRIER SCREENING, BY REGION, 2021-2028 (USD MILLION)

8 CARRIER SCREENING MARKET, BY MEDICAL CONDITION (Page No. - 90)
8.1 INTRODUCTION
TABLE 24 CARRIER SCREENING INDUSTRY, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
8.2 PULMONARY CONDITIONS
8.2.1 INCREASING AWARENESS ABOUT CYSTIC FIBROSIS IN REPRODUCTIVE PLANNING TO DRIVE MARKET
TABLE 25 LIVE BIRTH INCIDENCE OF CYSTIC FIBROSIS
TABLE 26 CARRIER SCREENING PRODUCTS/SERVICES FOR CYSTIC FIBROSIS
TABLE 27 MARKET FOR PULMONARY CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
8.3 HEMATOLOGICAL CONDITIONS
8.3.1 RISING PREVALENCE OF HEMATOLOGICAL DISORDERS AMONG INFANTS TO DRIVE MARKET
TABLE 28 MARKET FOR HEMATOLOGICAL CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
8.4 NEUROLOGICAL CONDITIONS
8.4.1 INCREASED AWARENESS OF NEUROLOGICAL SCREENING AND PRESENCE OF TARGETED SCREENING PANELS TO DRIVE MARKET
TABLE 29 GLOBAL PREVALENCE OF NEUROLOGICAL CONDITIONS
TABLE 30 CARRIER SCREENING PRODUCTS/SERVICES FOR NEUROLOGICAL CONDITIONS
TABLE 31 MARKET FOR NEUROLOGICAL CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
8.5 OTHER MEDICAL CONDITIONS
TABLE 32 MARKET FOR OTHER MEDICAL CONDITIONS, BY REGION, 2021-2028 (USD MILLION)

9 CARRIER SCREENING MARKET, BY TECHNOLOGY (Page No. - 98)
9.1 INTRODUCTION
TABLE 33 CARRIER SCREENING INDUSTRY, BY TECHNOLOGY, 2021-2028 (USD MILLION)
9.2 DNA SEQUENCING
9.2.1 DNA SEQUENCING SEGMENT TO DOMINATE MARKET DURING STUDY PERIOD
TABLE 34 DNA SEQUENCING USED BY MARKET PLAYERS
TABLE 35 MARKET FOR DNA SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
9.3 PCR
9.3.1 HIGH ACCURACY, LOW REACTION TIME, AND ABSOLUTE ESTIMATION OF TARGET MOLECULE TO DRIVE MARKET
TABLE 36 PCR USED BY MARKET PLAYERS
TABLE 37 MARKET FOR PCR, BY REGION, 2021-2028 (USD MILLION)
9.4 DNA MICROARRAYS
9.4.1 ABILITY TO ANALYZE MULTIPLE GENETIC MARKERS IN SINGLE ASSAY TO DRIVE MARKET
TABLE 38 DNA MICROARRAYS USED BY MARKET PLAYERS
TABLE 39 MARKET FOR DNA MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
9.5 OTHER TECHNOLOGIES
TABLE 40 ADVANTAGES OF OTHER TECHNOLOGIES FOR CARRIER SCREENING
TABLE 41 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)

10 CARRIER SCREENING MARKET, BY END USER (Page No. - 104)
10.1 INTRODUCTION
TABLE 42 CARRIER SCREENING INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.2 HOSPITALS AND MEDICAL CENTERS
10.2.1 RISING PATIENT POPULATION AND INCREASING MEDICARE REIMBURSEMENT FOR CLINICAL TESTS TO DRIVE SEGMENT
TABLE 43 MARKET FOR HOSPITALS AND MEDICAL CENTERS, BY REGION, 2021-2028 (USD MILLION)
10.3 CLINICAL LABORATORIES
10.3.1 LOWER SERVICE COSTS AND HIGHER TURNAROUND TIME TO DRIVE MARKET
TABLE 44 MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
10.4 FERTILITY CLINICS
10.4.1 INCREASING NUMBER OF INFERTILE COUPLES AND GROWING MEDICAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET
TABLE 45 MARKET FOR FERTILITY CLINICS, BY REGION, 2021-2028 (USD MILLION)
10.5 OTHER END USERS
TABLE 46 MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

11 CARRIER SCREENING MARKET, BY REGION (Page No. - 110)
11.1 INTRODUCTION
TABLE 47 CARRIER SCREENING INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 32 NORTH AMERICA: CARRIER SCREENING MARKET SNAPSHOT
TABLE 48 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 49 NORTH AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 50 NORTH AMERICA: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 51 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 52 NORTH AMERICA: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 53 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 54 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
11.2.1 NORTH AMERICA: RECESSION IMPACT
11.2.2 US
11.2.2.1 Increasing number of genetic diseases and rising healthcare expenditure to drive market
TABLE 55 US: KEY MACROINDICATORS
TABLE 56 US: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 57 US: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 58 US: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 59 US: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 60 US: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 61 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Increasing government and non-government funding to drive market
TABLE 62 CANADA: KEY MACROINDICATORS
TABLE 63 CANADA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 64 CANADA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 65 CANADA: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 66 CANADA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 67 CANADA: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 68 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3 EUROPE
TABLE 69 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
11.3.1 EUROPE: RECESSION IMPACT
TABLE 70 EUROPE: CARRIER SCREENING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 72 EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 73 EUROPE: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 74 EUROPE: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 75 EUROPE: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 76 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Increasing number of government initiatives and healthcare expenditures to drive market
TABLE 77 GERMANY: KEY MACROINDICATORS
TABLE 78 GERMANY: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 79 GERMANY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 80 GERMANY: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 81 GERMANY: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 82 GERMANY: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 83 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising prevalence of hematological disease and increasing number of accredited clinical laboratories to drive market
TABLE 84 UK: KEY MACROINDICATORS
TABLE 85 UK: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 86 UK: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 87 UK: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 88 UK: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 89 UK: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 90 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Better healthcare infrastructure and higher expenditure for life science research to drive market
TABLE 91 FRANCE: KEY MACROINDICATORS
TABLE 92 FRANCE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 93 FRANCE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 94 FRANCE: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 FRANCE: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 96 FRANCE: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 97 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Growing prevalence of chronic diseases and rising number of hospitals to drive market
TABLE 98 ITALY: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 99 ITALY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 100 ITALY: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 101 ITALY: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 102 ITALY: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 103 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increasing prevalence of rare genetic diseases and rising availability of research funding to drive market
TABLE 104 SPAIN: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 105 SPAIN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 106 SPAIN: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 107 SPAIN: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 108 SPAIN: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 109 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 110 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP)
TABLE 111 REST OF EUROPE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 112 REST OF EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 113 REST OF EUROPE: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 114 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 115 REST OF EUROPE: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 116 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 33 ASIA PACIFIC: CARRIER SCREENING MARKET SNAPSHOT
TABLE 117 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 118 ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 119 ASIA PACIFIC: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.2 INDIA
11.4.2.1 Growing incidence of rare diseases and declining fertility rates to drive market
TABLE 123 INDIA: KEY MACROINDICATORS
TABLE 124 INDIA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 125 INDIA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 126 INDIA: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 127 INDIA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 128 INDIA: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 129 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Rising focus on vaccine development and cancer research to drive market
TABLE 130 CHINA: KEY MACROINDICATORS
TABLE 131 CHINA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 132 CHINA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 133 CHINA: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 134 CHINA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 135 CHINA: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 136 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.4 JAPAN
11.4.4.1 Rising geriatric population and growing government healthcare expenditure to drive market
TABLE 137 JAPAN: KEY MACROINDICATORS
TABLE 138 JAPAN: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 139 JAPAN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 140 JAPAN: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 141 JAPAN: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 142 JAPAN: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 143 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 144 REST OF ASIA PACIFIC: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 145 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 146 REST OF ASIA PACIFIC: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 147 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 148 REST OF ASIA PACIFIC: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 149 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5 REST OF THE WORLD
11.5.1 REST OF THE WORLD: RECESSION IMPACT
TABLE 150 REST OF THE WORLD: CARRIER SCREENING MARKET, BY PRODUCT & 2021-2028 (USD MILLION)
TABLE 151 REST OF THE WORLD: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 152 REST OF THE WORLD: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 153 REST OF THE WORLD: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 154 REST OF THE WORLD: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 155 REST OF THE WORLD: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.2 LATIN AMERICA
11.5.2.1 Higher prevalence of genetic disorders and growing focus on reproductive healthcare services to drive market
TABLE 156 DEFINITION OF RARE DISEASES IN VARIOUS COUNTRIES
TABLE 157 LATIN AMERICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 158 LATIN AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 159 LATIN AMERICA: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 160 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 161 LATIN AMERICA: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 162 LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.3 MIDDLE EAST & AFRICA
TABLE 163 MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.3.1 GCC Countries
11.5.3.1.1 Improved healthcare infrastructure and launch of genome projects to drive market
TABLE 169 GCC COUNTRIES: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 170 GCC COUNTRIES: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 171 GCC COUNTRIES: MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
TABLE 172 GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 173 GCC COUNTRIES: MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
TABLE 174 GCC COUNTRIES: MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 174)
12.1 OVERVIEW
12.2 KEY STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 175 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CARRIER SCREENING MARKET
12.3 MARKET SHARE ANALYSIS
TABLE 176 DEGREE OF COMPETITION: CARRIER SCREENING INDUSTRY
12.4 REVENUE SHARE ANALYSIS
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 35 COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT
TABLE 177 OVERALL COMPANY FOOTPRINT
TABLE 178 PRODUCT FOOTPRINT
TABLE 179 REGIONAL FOOTPRINT
12.6 START-UP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 36 START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 180 DETAILED LIST OF KEY START-UPS/SMES IN CARRIER SCREENING INDUSTRY
12.7 COMPETITIVE SCENARIOS AND TRENDS
12.7.1 KEY DEALS
TABLE 181 KEY DEALS, JANUARY 2020-DECEMBER 2023

13 COMPANY PROFILES (Page No. - 184)
13.1 KEY PLAYERS
(Business overview, Products/Services/Solutions offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)*
13.1.1 NATERA, INC.
TABLE 182 NATERA, INC.: COMPANY OVERVIEW
FIGURE 37 NATERA, INC.: COMPANY SNAPSHOT (2022)
13.1.2 QUEST DIAGNOSTICS INCORPORATED
TABLE 183 QUEST DIAGNOSTICS INCORPORATED: COMPANY OVERVIEW
FIGURE 38 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2022)
13.1.3 FULGENT GENETICS
TABLE 184 FULGENT GENETICS: COMPANY OVERVIEW
FIGURE 39 FULGENT GENETICS.: COMPANY SNAPSHOT (2022)
13.1.4 INVITAE CORPORATION
TABLE 185 INVITAE CORPORATION: COMPANY OVERVIEW
FIGURE 40 INVITAE CORPORATION.: COMPANY SNAPSHOT (2022)
13.1.5 EUROFINS SCIENTIFIC
TABLE 186 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
13.1.6 OPKO HEALTH, INC.
TABLE 187 OPKO HEALTH, INC.: COMPANY OVERVIEW
FIGURE 42 OPKO HEALTH, INC.: COMPANY SNAPSHOT (2022)
13.1.7 THERMO FISHER SCIENTIFIC INC.
TABLE 188 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
13.1.8 MYRIAD GENETICS, INC.
TABLE 189 MYRIAD GENETICS, INC.: COMPANY OVERVIEW
FIGURE 44 MYRIAD GENETICS, INC.: COMPANY SNAPSHOT (2022)
13.1.9 ILLUMINA, INC.
TABLE 190 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 45 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
13.1.10 LABORATORY CORPORATION OF AMERICA HOLDINGS
TABLE 191 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
FIGURE 46 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)
13.1.11 CENTOGENE N.V.
TABLE 192 CENTOGENE N.V.: COMPANY OVERVIEW
FIGURE 47 CENTOGENE N.V.: COMPANY SNAPSHOT (2022)
13.1.12 DIASORIN S.P.A.
TABLE 193 DIASORIN S.P.A.: COMPANY OVERVIEW
FIGURE 48 DIASORIN S.P.A.: COMPANY SNAPSHOT (2023)
13.1.13 BGI
TABLE 194 BGI: COMPANY OVERVIEW
13.1.14 OTOGENETICS
TABLE 195 OTOGENETICS: COMPANY OVERVIEW
13.1.15 GENETECH
TABLE 196 GENETECH: COMPANY OVERVIEW
13.2 OTHER PLAYERS
13.2.1 OXY-GEN LABORATORY LLC
TABLE 197 OXY-GEN LABORATORY LLC: COMPANY OVERVIEW
13.2.2 MEDGENOME
TABLE 198 MEDGENOME: COMPANY OVERVIEW
13.2.3 AMBRY GENETICS.
TABLE 199 AMBRY GENETICS: COMPANY OVERVIEW
13.2.4 ASPER BIOGENE
TABLE 200 ASPER BIOGENE: COMPANY OVERVIEW
13.2.5 LIFELABS GENETICS
TABLE 201 LIFELABS GENETICS: COMPANY OVERVIEW
13.2.6 EASYDNA
TABLE 202 EASYDNA: COMPANY OVERVIEW
13.2.7 LIFECELL
TABLE 203 LIFECELL: COMPANY OVERVIEW
13.2.8 CNC PATH LAB
TABLE 204 CNC PATH LAB: COMPANY OVERVIEW
13.2.9 SIGNATURE DIAGNOSTICS INC.
TABLE 205 SIGNATURE DIAGNOSTICS INC.: COMPANY OVERVIEW
13.2.10 MITERA
TABLE 206 MITERA: COMPANY OVERVIEW
*Details on Business overview, Products/Services/Solutions offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 226)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS